{"id":"rsvpref-vaccine","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Live, attenuated influenza vaccines","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated varicella vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated MMR vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated yellow fever vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral typhoid vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral rotavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral human papillomavirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated nasal influenza vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"},{"drug":"Live, attenuated oral poliovirus vaccine","action":"Avoid","effect":"May diminish the therapeutic effect of RSVpreF Vaccine"}],"contraindications":["Severe allergic reaction (e.g., anaphylaxis) to a previous dose of RSVpreF Vaccine or to any of its components"]},"trials":[],"_chembl":null,"aliases":[],"company":"Pfizer Inc.","patents":[],"pricing":[],"_fixedAt":"2026-03-30T11:39:24.670605","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=rsvpref-vaccine","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:51:58.749255+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:52:04.299772+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:51:58.820813+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=rsvpref-vaccine","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:52:04.639715+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108573/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:52:05.355106+00:00"}},"allNames":"rsvpref vaccine","offLabel":[],"timeline":[],"_dailymed":null,"aiSummary":"The RSVpreF Vaccine, developed by Pfizer Inc., is a marketed drug that prevents severe lower respiratory tract disease caused by RSV in high-risk infants. It has undergone 26 clinical trials and has been the subject of 81 publications. The vaccine's commercial significance lies in its ability to address a critical public health need. However, its revenue figures are not publicly available. The vaccine's mechanism of action is not explicitly stated. Its key indication is the prevention of RSV-associated hospitalization in high-risk infants. The vaccine's clinical differentiation lies in its ability to provide protection against severe RSV disease. The vaccine's pipeline developments are not specified.","brandName":"RSVpreF Vaccine","ecosystem":[],"isGeneric":true,"mechanism":{"target":"RSV","novelty":"best-in-class","modality":"vaccine","drugClass":"vaccine","explanation":"","oneSentence":"","technicalDetail":"The RSVpreF Vaccine is a type of vaccine that uses a prefusion F protein to stimulate an immune response against RSV. This protein is designed to mimic the structure of the RSV virus, allowing the immune system to recognize and attack it. The vaccine is administered to high-risk infants to provide protection against severe RSV disease."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"_scrapedAt":"2026-03-27T23:28:53.643Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"annualCostUS":"Generic pricing varies by manufacturer","genericStatus":"Generic — off-patent","peakSalesEstimate":"Not publicly reported"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=rsvpref-vaccine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=rsvpref-vaccine","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:52:07.177934+00:00","fieldsConflicting":1,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Paxlovid","company":"Pfizer","advantage":"Paxlovid is an oral antiviral medication that competes with RSVpreF Vaccine by providing a treatment option for COVID-19, a similar respiratory virus.","genericName":"Nirmatrelvir/ritonavir"},{"name":"Xofluza","company":"Shionogi","advantage":"Xofluza is an oral antiviral medication that competes with RSVpreF Vaccine by providing a treatment option for influenza, a similar respiratory virus.","genericName":"Baloxavir marboxil"},{"name":"Tamiflu","company":"Roche","advantage":"Tamiflu is an oral antiviral medication that competes with RSVpreF Vaccine by providing a treatment option for influenza, a similar respiratory virus.","genericName":"Oseltamivir"}],"genericName":"rsvpref-vaccine","indications":{"approved":[{"name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants with a high risk of RSV-associated hospitalization due to prematurity.","regulator":"FDA"},{"name":"Prevention of severe lower respiratory tract disease caused by respiratory syncytial virus (RSV) in young children with a history of premature birth or bronchopulmonary dysplasia.","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_fixedFields":["pubmed(81)"],"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06551506","phase":"PHASE4","title":"The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-09-19","conditions":"Respiratory Syncytial Virus Infection","enrollment":181},{"nctId":"NCT06866405","phase":"PHASE3","title":"A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-04-16","conditions":"RSV Infection","enrollment":550},{"nctId":"NCT07097012","phase":"PHASE4","title":"Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy","status":"RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2025-10-16","conditions":"RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Pregnancy","enrollment":60},{"nctId":"NCT07445763","phase":"","title":"TARSILA Real-World Evidence Study","status":"NOT_YET_RECRUITING","sponsor":"Inova Medical","startDate":"2026-04-30","conditions":"Respiratory Syncytial Virus (RSV), Maternal Immunization, Acute Respiratory Illness (ARI)","enrollment":5000},{"nctId":"NCT06593587","phase":"PHASE3","title":"A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-10-07","conditions":"Respiratory Syncytial Virus","enrollment":378},{"nctId":"NCT06546800","phase":"","title":"SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2025-05-27","conditions":"Respiratory Syncytial Virus Infection","enrollment":1100},{"nctId":"NCT05035212","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2021-08-31","conditions":"Lower Respiratory Tract Illness","enrollment":38861},{"nctId":"NCT07296120","phase":"PHASE4","title":"RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients","status":"NOT_YET_RECRUITING","sponsor":"The Cooper Health System","startDate":"2026-01-01","conditions":"CAR-T Cell Therapy, RSV Immunization, Bone Marrow Transplant - Autologous or Allogeneic","enrollment":30},{"nctId":"NCT07279298","phase":"","title":"Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV","status":"NOT_YET_RECRUITING","sponsor":"Bogotá District Health Secretariat","startDate":"2026-02-01","conditions":"Respiratory Syncytial Virus Infections, Severe Acute Respiratory Infection, Bronchiolitis, Viral","enrollment":1097},{"nctId":"NCT06684743","phase":"PHASE4","title":"Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults","status":"RECRUITING","sponsor":"Tor Biering-Sørensen","startDate":"2024-11-18","conditions":"RSV","enrollment":690000},{"nctId":"NCT06482099","phase":"","title":"SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-10-01","conditions":"Respiratory Tract Infection","enrollment":497},{"nctId":"NCT07122661","phase":"","title":"STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2025-08-11","conditions":"Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus, Lower Respiratory Tract Disease","enrollment":1},{"nctId":"NCT06890416","phase":"PHASE3","title":"A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-04-04","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":526},{"nctId":"NCT06077149","phase":"PHASE4","title":"Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2023-11-07","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":152},{"nctId":"NCT06647654","phase":"","title":"Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-08-26","conditions":"Respiratory Syncytial Virus, Respiratory Tract Diseases","enrollment":1},{"nctId":"NCT06473519","phase":"PHASE3","title":"A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-06-24","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":453},{"nctId":"NCT05842967","phase":"PHASE3","title":"A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-05-11","conditions":"RESPIRATORY SYNCYTIAL VIRUS (RSV)","enrollment":885},{"nctId":"NCT06325657","phase":"PHASE3","title":"A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-03-12","conditions":"Respiratory Syncytial Virus","enrollment":648},{"nctId":"NCT06955728","phase":"PHASE4","title":"A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.","status":"NOT_YET_RECRUITING","sponsor":"University of Witwatersrand, South Africa","startDate":"2025-05-01","conditions":"RSV Infections, RSV Immunisation, Preterm Labour","enrollment":13000},{"nctId":"NCT05900154","phase":"PHASE1","title":"A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-06-22","conditions":"RESPIRATORY SYNCYTIAL VIRUS (RSV)","enrollment":128},{"nctId":"NCT04424316","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-06-17","conditions":"Respiratory Tract Infection","enrollment":14727},{"nctId":"NCT05886777","phase":"PHASE2","title":"A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-06-05","conditions":"Healthy Participants","enrollment":1142},{"nctId":"NCT05788237","phase":"PHASE1","title":"A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-03-09","conditions":"Healthy","enrollment":508},{"nctId":"NCT04785612","phase":"PHASE2","title":"Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults","status":"COMPLETED","sponsor":"Hvivo","startDate":"2020-11-10","conditions":"Respiratory Syncytial Virus Infections","enrollment":70},{"nctId":"NCT05301322","phase":"PHASE3","title":"Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-04-13","conditions":"Respiratory Syncytial Virus","enrollment":1471},{"nctId":"NCT05096208","phase":"PHASE3","title":"Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-10-21","conditions":"RSV","enrollment":1028}],"_emaApprovals":[{"date":"","name":"RSVpreF Vaccine","status":"Authorised","regulator":"EMA"}],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component","molecularWeight":""},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL2108573"},"formularyStatus":[],"_approvalHistory":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":84,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 26","pmid":"41888891","title":"Disease burden estimates in economic evaluation studies of Respiratory Syncytial Virus (RSV) maternal immunization: a systematic review protocol.","journal":"Systematic reviews"},{"date":"2026 Apr 7","pmid":"41876434","title":"Health and Economic Impact of Seasonal Maternal Vaccination With Bivalent Respiratory Syncytial Virus Prefusion F Vaccine in Belgium.","journal":"The Pediatric infectious disease journal"},{"date":"2026 Feb 26","pmid":"41759886","title":"Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong.","journal":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"date":"2026 Jan 28","pmid":"41746051","title":"Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds.","journal":"Vaccines"},{"date":"2026 Feb 27","pmid":"41741000","title":"Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.","journal":"Archives of disease in childhood"}],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"approved","companyName":"Pfizer Inc.","companyId":"pfizer","modality":"Vaccine","firstApprovalDate":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":2},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:52:07.177934+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}